Sarepta Therapeutics, Inc. (SRPT) Social Stream



Sarepta Therapeutics, Inc. (SRPT): $72.77

-1.25 (-1.69%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SRPT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 492

in industry

Featured Post From StockTwits About SRPT

$SRPT Alright heres my call, its treking back to 83.18 by the eps ~May 6th. I added a call about an hour ago and Im chasing some more as I type. The earnings update will confirm a sentiment pivot but the price will recalibrare over the 50ma 79.5 and near that 83r level. Lock and load suckas.

Doug will be coming for that 125
Surfcasterdb, published April 26, 2021

What Else are SRPT Traders Talking About?


Other tickers frequently mentioned alongside SRPT are RHHBY, PFE, CERC and AKBA.

Other Notable StockTweets About SRPT


$SRPT just bought a decent position at this level. Extremely undervalued and oversold. Revenue stream is solid and only projected to increase a ton. Yeah, had a failed test. But they have over 40 more programs in the pipeline. It’ll be shorted and manipulated more, I’m sure. But if you just buy in and hold at these levels, we should be able to profit handsomely in the near future (and when I say “near,” I mean a year or so. Some I trade, and others are an investment. The latter is what this one is for me).

stardrunk, published April 22, 2021

$SRPT IF $RHHBY is so dumb not to make a bid on Sarepta while sub $6B market cap, $PFE should take their vax cash and buy it. $PFE didn’t have any luck with their DMD research, they would be stupid not to act now. Walk away from the Roche Deal, $PFE will pay nice premium for Sarepta.

free2dream, published April 16, 2021

$SRPT Interesting to see all the negative comments on Doug Ingram recently. Understand that the XBI biotech index has dropped 25%+ from its highs over the last few weeks. This is a substantial move and has brought the entire sector down.

Some people have simply not been around long enough to know how good of a CEO Doug is and how he has transformed this company. I've been long since the low teens.

Great company and great opportunity to add or start a position.

AlphaJPL, published April 9, 2021

$CERC Good bounce from 2.79$ - 4 possible PRV upon approval. 1 PRV- voucher is worth 100-350 million dollar. $SRPT sold Vifor 1 PRV-Voucher for 110 million dollar $AKBA (Vifor consider to resell it with AKBA for 100 million to increase balance sheet/both comfirmed me via e-mail)

CERC 270 million market - possible 4 PRV = 440 million market cap without cashbalance + pipeline value. It looks like a good year longterm for CERC.

No position yet but 🧐💙

MamamooTwits, published April 1, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4888 seconds.